VUNO will exhibit its AI-powered cardiac arrest risk monitoring device, VUNO Med-DeepCARS, at the 44th Korean Society of Critical Care Medicine (KSCCM) Annual Congress-Acute and Critical Care Congress 2024, which will be held from Thursday to Friday.The company plans to showcase the superiority and
Professor Bang Jae-seung, chairman of the emergency committee of the Seoul National University College of Medicine and Seoul National University Hospital (SNUH) faculty council, will lay down both the chairmanship and professorship.Bang and three other medical professors who served on the emergency
Viatris Korea celebrated 25 years of Lpitor (atorvastatin) sales in Korea, highlighting its pivotal role in dyslipidemia treatment and cardiovascular diseases (CVD) prevention at a press conference in Seoul on Wednesday.After its launch in 1997, Lipitor became the top-prescribed statin in Korea by 2
Chong Kun Dang said it has entered into a licensing agreement with Curigin, a local gene therapy developer, for the latter's CA102, a gene therapy candidate targeting superficial bladder cancer.Founded in 2016, Curigin has pioneered the development of siRNA technologies capable of suppressing multip
"We are very sorry that we will be unable to be by your side."That's what the Department of Pediatric Nephrology professors at Seoul National University Hospital (SNUH) wrote in a notice to patients informing them of their resignations on Aug. 31. Only two professors are now working in the departmen
Attention is drawn to whether the reimbursement criteria for the multiple myeloma drug Darzalex (daratumumab), unchanged since May 2021, will be expanded for the first time in three years.Proposals to expand the reimbursement standard for the DVd (daratumumab/bortezomib/dexamethasone) and DKd (darat
Senior physicians at Seoul National University Hospital (SNUH) and Asan Medical Center (AMC) said they decided to refuse surgery and outpatient care by taking a day off every week in a growing protest against the government’s push to increase medical school enrollment quota. The emergency response c
Hanmi Pharmaceutical said it has entered into a clinical trial collaboration and supply agreement (CTCSA) with Merck & Co., Inc., known as MSD outside the U.S. and Canada.The partnership is set to advance the clinical research of Hanmi's dual-antibody therapy, BH3120, combined with MSD's immunothera
Pharos iBio said it has signed a memorandum of understanding with MEDiC Life Sciences, a Silicon Valley-based company that has established a gene-scissor technology (CRISPR) based cancer target and biomarker discovery platform, to collaborate on drug discovery.Through this agreement, the two compani
Samsung Bioepis said it has secured final product approval from the European Commission (EC) for its latest biosimilar, Pyzchiva, also known as SB17, a biosimilar candidate referencing Stelara.Stelara, originally developed by Janssen, is used for treating plaque psoriasis, psoriatic arthritis, Crohn
A top government official recently said that professors at even private medical schools, let alone national ones, are subject to the National Civil Service Act, raising the possibility that the ongoing conflict between the government and the political community could turn into legal disputes."Vice M
Jung Kwan Jang, Korea’s top ginseng product manufacturer, said it conducted a seminar focused on the efficacy and safety of red ginseng during the International Conference on the Science of Botanicals, held in Oxford, Miss., from April 15 to 18.The International Conference on the Science of Botanica
GC Biopharma said it has submitted an investigational new drug (IND) application and applied for Fast Track Designation with the U.S. FDA for GC1130A, an intracerebroventricular (ICV) enzyme replacement therapy (ERT) drug for Sanfilippo Syndrome Type A (MPS IIIA), jointly developed with Korean biote
AI solutions developed by Korean medical artificial intelligence companies, including Lunit, have begun to be used in medical sites, raising expectations among market players and the medical community.On Tuesday last week, Lunit, Coreline Soft, and Deepnoid received the results of the National Evide
Celltrion's Remsima (infliximab) line of products continues to demonstrate market impact with expanded prescriptions in five major European countries—the U.K., Germany, France, Spain, and Italy—also known as EU5.According to pharmaceutical market research firm IQVIA, as of the fourth quarter of 2023
HK inno.N's GERD drug K-CAB has expanded its momentum to the Middle East and North Africa region.Starting from China and expanding across Asia and North and South America, K-CAB is increasing its global market dominance by advancing to the Middle East and North Africa markets, according to the compa
Kakao Healthcare said Tuesday that it has signed a business agreement with global food care and catering company OURHOME to develop AI-based ultra-personalized healthcare solutions jointly.Kakao Healthcare CEO Hwang Hee and OURHOME CEO Koo Ji-eun signed the memorandum of understanding at Kakao Healt
Curocell, a chimeric antigen receptor-T (CAR-T) developer, has applied for Anbal-cel, its CAR-T candidate, to be included in the Ministry of Food and Drug Safety (MFDS)’s Advanced Biomedicine Expedited Approval System.The system is designed to facilitate the rapid market entry of innovative medicine
In alignment with Earth Day, an annual event on April 22, Bayer Korea began its annual "Glück for Green" plogging campaign, an initiative designed to foster sustainable practices among its employees. Plogging refers to picking up rubbish while jogging or walkingThis year marks the third installment
Skyrizi (risankizumab) has emerged as a new option for treating palmoplantar pustulosis (PPP), a condition characterized by pustules, exfoliation, and red patches on the palms of the hands and feet that impair quality of life.AbbVie Korea held a media event on Monday to commemorate the approval of i